About Aquila BioMedical

Created in 2011 by academics from the University of Edinburgh, Aquila BioMedical provides novel investigative mode-of-action platforms in a quality controlled environment. World-leading experts in immunology, autoimmunity, inflammation, neuroscience and MS direct study programs on behalf of clients.

Based at Edinburgh BioQuarter, one of Europe's leading life science clusters, Aquila's mission is to enhance drug discovery and development programmes with new assays and deliver benefits for human health.